Skip to main content
. 2012 Jun 18;80(3):719–730. doi: 10.3797/scipharm.1202-06

Tab. 5.

Comparison of clinical symptoms between the study groups.

Frequency CVE group Control group p-Value

Pre-trial Post- trial p- value Pre-trial Post- trial p- value pre- trial post- trial
Coughing Almost every day 47.8% 3.5% 59.2% 13.8%
A few days a week 21.8% 25.0% 10.2% 6.8%
A few days a month 6.5% 10.7% 6.1% 10.3%
Only with lung/respiratory infections <0.001 <0.001 0.66 0.35
21.8% 35.7% 20.4% 27.5%
Not at all 2.2% 25.0% 4.1% 41.3%

Shortness of breath Almost every day 73.9% 10.7% 67.3% 13.7%
A few days a week 17.3% 25.0% 20.4% 10.3%
A few days a month 2.2% 17.8% 6.1% 27.6%
Only with lung/respiratory infections <0.001 <0.001 0.49 0.70
4.3% 21.4% 6.1% 20.6%
Not at all 2.2% 25.0% 0.0% 27.6%

Wheezing Almost every day 84.7% 4.3% 63.2% 6.8%
A few days a week 8.6% 42.8% 18.3% 13.7%
A few days a month 4.3% 8.6% 4.1% 24.1%
Only with lung/respiratory infections <0.001 <0.001 0.01 0.07
2.1% 4.3% 8.1% 10.3%
Not at all 0.0 17.3 6.1 44.8

Sputum brought up Almost every day 47.8 3.5 59.2 24.1
A few days a week 21.8 7.1 10.2 17.24
A few days a month 6.5 10.7 6.1 6.8
Only with lung/respiratory infections <0.001 <0.001 0.50 0.02
21.8 57.1 20.4 37.9
Not at all 2.2 21.4 4.1 13.7